What is Caribou Biosciences, Inc. Common Stock's Market Cap?

Caribou Biosciences, Inc. Common Stock's Market Cap is $165.1M, based on as-reported figures from SEC (XBRL) filings.

What is Caribou Biosciences, Inc. Common Stock's Enterprise Value?

Caribou Biosciences, Inc. Common Stock's Enterprise Value is $138.9M, based on as-reported figures from SEC (XBRL) filings.

What is Caribou Biosciences, Inc. Common Stock's Price / Sales?

Caribou Biosciences, Inc. Common Stock's Price / Sales is 16.5×, based on as-reported figures from SEC (XBRL) filings.

What is Caribou Biosciences, Inc. Common Stock's EV / Revenue?

Caribou Biosciences, Inc. Common Stock's EV / Revenue is 13.8×, based on as-reported figures from SEC (XBRL) filings.

What is Caribou Biosciences, Inc. Common Stock's EV / EBITDA?

Caribou Biosciences, Inc. Common Stock's EV / EBITDA is n/m, based on as-reported figures from SEC (XBRL) filings.

What is Caribou Biosciences, Inc. Common Stock's Revenue (TTM)?

Caribou Biosciences, Inc. Common Stock's Revenue (TTM) is $10.0M, based on as-reported figures from SEC (XBRL) filings.

What is Caribou Biosciences, Inc. Common Stock's Net Income (TTM)?

Caribou Biosciences, Inc. Common Stock's Net Income (TTM) is -$103.4M, based on as-reported figures from SEC (XBRL) filings.

What is Caribou Biosciences, Inc. Common Stock's EBITDA?

Caribou Biosciences, Inc. Common Stock's EBITDA is -$106.9M, based on as-reported figures from SEC (XBRL) filings.

What is Caribou Biosciences, Inc. Common Stock's Diluted EPS (TTM)?

Caribou Biosciences, Inc. Common Stock's Diluted EPS (TTM) is -0.96, based on as-reported figures from SEC (XBRL) filings.

What is Caribou Biosciences, Inc. Common Stock's EBITDA Margin?

Caribou Biosciences, Inc. Common Stock's EBITDA Margin is -1065.1%, based on as-reported figures from SEC (XBRL) filings.

Caribou Biosciences, Inc. Common Stock (CRBU) Financial Statements

Caribou Biosciences, Inc. Common Stock

SIC 2836 · BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)

FIGI BBG008G28LH7

XNAS · usd

1.54▼ 0.03 (-1.91%)

As of 2026-09-08

Valuation

Market Cap

Enterprise Value

Trailing P/E—

Price / Sales

EV / Revenue

EV / EBITDA

Financial Highlights

Revenue (TTM)

Net Income (TTM)

EBITDA

Diluted EPS (TTM)

EBITDA Margin

Net Debt

Trading Information

Previous Close1.57

Day's Range1.54 – 1.58

52-Week Range1.38 – 3.54

Volume683.5K

Avg Volume1.0M

Share Statistics

Shares Outstanding

Employees97

ExchangeXNAS

Listed2021-07-23

Share count as of August 7, 2026

ViewDetail

Period

Loading Income Statement…

Key questions about Caribou Biosciences, Inc. Common Stock (CRBU)

What is Caribou Biosciences, Inc. Common Stock's Market Cap?: Caribou Biosciences, Inc. Common Stock's Market Cap is $165.1M, based on as-reported figures from SEC (XBRL) filings.
What is Caribou Biosciences, Inc. Common Stock's Enterprise Value?: Caribou Biosciences, Inc. Common Stock's Enterprise Value is $138.9M, based on as-reported figures from SEC (XBRL) filings.
What is Caribou Biosciences, Inc. Common Stock's Price / Sales?: Caribou Biosciences, Inc. Common Stock's Price / Sales is 16.5×, based on as-reported figures from SEC (XBRL) filings.
What is Caribou Biosciences, Inc. Common Stock's EV / Revenue?: Caribou Biosciences, Inc. Common Stock's EV / Revenue is 13.8×, based on as-reported figures from SEC (XBRL) filings.
What is Caribou Biosciences, Inc. Common Stock's EV / EBITDA?: Caribou Biosciences, Inc. Common Stock's EV / EBITDA is n/m, based on as-reported figures from SEC (XBRL) filings.
What is Caribou Biosciences, Inc. Common Stock's Revenue (TTM)?: Caribou Biosciences, Inc. Common Stock's Revenue (TTM) is $10.0M, based on as-reported figures from SEC (XBRL) filings.
What is Caribou Biosciences, Inc. Common Stock's Net Income (TTM)?: Caribou Biosciences, Inc. Common Stock's Net Income (TTM) is -$103.4M, based on as-reported figures from SEC (XBRL) filings.
What is Caribou Biosciences, Inc. Common Stock's EBITDA?: Caribou Biosciences, Inc. Common Stock's EBITDA is -$106.9M, based on as-reported figures from SEC (XBRL) filings.
What is Caribou Biosciences, Inc. Common Stock's Diluted EPS (TTM)?: Caribou Biosciences, Inc. Common Stock's Diluted EPS (TTM) is -0.96, based on as-reported figures from SEC (XBRL) filings.
What is Caribou Biosciences, Inc. Common Stock's EBITDA Margin?: Caribou Biosciences, Inc. Common Stock's EBITDA Margin is -1065.1%, based on as-reported figures from SEC (XBRL) filings.